The KDIGO guideline recommends screening individuals at risk for CKD, including those with CAKUT, recurrent kidney stones, and known genetic variants associated with CKD, through both urine albumin measurement and GFR assessment [13]. This evidence concerns the gene ALB and nephrolithiasis.